Novavax, Inc. (NVAX) earnings
NVAX earnings moved a median of -0.46% by the close. Quarterly and annual NVAX reports and results, each read against the price at its own news timestamp. Back to the NVAX overview →
30 measured NVAX earnings events.
Where these NVAX earnings landedvs 30 measured NVAX earnings reactions
| Middle 50% of NVAX earnings reactions | -4.74% to +4.70% |
|---|---|
| Median reaction (to close) | -0.46% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 NVAX earnings events with a measured close landed between -4.74% and +4.70%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NOVAVAX INC For: Jun 30 | SEC filing · Form 10-Q | -2.66% | -1.28% | |
| Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights | Press release | -2.66% | -1.28% | |
| Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -1.08% | +0.14% | |
| Form 10-Q NOVAVAX INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +9.35% | |
| Novavax Reports First Quarter 2026 Financial Results and Operational Highlights | Press release | +0.00% | +9.35% | |
| Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 | Press release | +0.13% | -1.06% | |
| Form 10-K NOVAVAX INC For: Dec 31 | SEC filing · Form 10-K | +5.44% | +14.77% | |
| Form 10-Q NOVAVAX INC For: Sep 30 | SEC filing · Form 10-Q | +3.21% | +1.47% | |
| Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights | Press release | +3.21% | +1.47% | |
| Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.54% | +1.57% | |
| Form 10-Q NOVAVAX INC For: Jun 30 | SEC filing · Form 10-Q | +6.50% | +4.70% | |
| Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights | Press release | +6.50% | +4.70% | |
| Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | -0.02% | -3.27% | |
| Form 10-Q NOVAVAX INC For: Mar 31 | SEC filing · Form 10-Q | -3.19% | -7.50% | |
| Novavax Reports First Quarter 2025 Financial Results and Operational Highlights | Press release | -3.19% | -7.50% | |
| Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | -4.74% | -3.46% | |
| Form 10-K NOVAVAX INC For: Dec 31 | SEC filing · Form 10-K | +5.84% | -6.24% | |
| Form 10-Q NOVAVAX INC For: Sep 30 | SEC filing · Form 10-Q | -1.54% | -7.89% | |
| Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights | Press release | +5.59% | +5.09% | |
| Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 | Press release | +0.11% | +4.89% | |
| Form 10-Q NOVAVAX INC For: Jun 30 | SEC filing · Form 10-Q | +3.99% | +29.49% | |
| Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights | Press release | +3.99% | +29.49% | |
| Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024 | Press release | +1.32% | +3.97% | |
| Form 10-Q NOVAVAX INC For: Mar 31 | SEC filing · Form 10-Q | +1.73% | -11.20% | |
| Novavax Reports First Quarter 2024 Financial Results and Operational Highlights | Press release | +1.73% | -11.20% | |
| Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024 | Press release | -3.04% | -6.68% | |
| Form 10-K NOVAVAX INC For: Dec 31 | SEC filing · Form 10-K | -6.67% | -5.16% | |
| Form 10-Q NOVAVAX INC For: Sep 30 | SEC filing · Form 10-Q | -2.02% | -3.17% | |
| Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights | Press release | -2.02% | -3.17% | |
| Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023 | Press release | +0.94% | +2.73% |
Keep exploring
More NVAX: analyst actions → · SEC filings → · NVAX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EDGE THERAPEUTICS (EDGE) | 401 | -0.05% | 41% |
| Esperion Therapeutics, Inc. (ESPR) | 401 | 0.00% | 47% |
| AMEDICA CORP COMMON STOCK (AMDA) | 397 | -1.09% | 31% |
| PAIN THERAPEUTICS (PTIE) | 397 | -0.01% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.